Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
N Engl J Med
.
2017 Nov 23;377(21):2099.
doi: 10.1056/NEJMc1712572.
Authors
Bruce Neal
1
2
,
Vlado Perkovic
1
,
David R Matthews
3
Affiliations
1
George Institute for Global Health, Sydney, NSW, Australia
2
bneal@georgeinstitute.org.au
3
University of Oxford, Oxford, United Kingdom
PMID:
29166232
DOI:
10.1056/NEJMc1712572
No abstract available
Publication types
Letter
Comment
MeSH terms
Canagliflozin*
Diabetes Mellitus, Type 2*
Glucosides
Humans
Hypoglycemic Agents
Kidney
Sodium-Glucose Transporter 2
Substances
Glucosides
Hypoglycemic Agents
Sodium-Glucose Transporter 2
Canagliflozin